Ìý
Co-location
Ìý

Boost your business potential by co-locating on a ÑÇÃÀÆåÅÆ campus. From collaboration with world-leading researchers to custom-built facilities, our campus has plenty to offer entrepreneurs.
Benefits include:
- Extra incentives and opportunities to outsource your R&D challenges.
- Access to laboratories and makerspaces throughout the campus footprint.
- A library card that opens the door to our collection of books, journals, newspapers, electronic resources, multimedia and online databases.
- Opportunities for lifelong learning with the Australian Graduate School of Management and the Australian Graduate School of Engineering.
- The chance to connect with talented students and PhDs eager to take part in your projects.
Meet our co-locators
-
-
Bondi Bio has built a novel platform for the biomanufacture and delivery of biologics. Based on bioengineered, food-grade cyanobacteria, the platform offers a scalable solution for a range of therapeutic modalities including VLP-based vaccines, therapeutic proteins and peptides, nucleic-acid-based treatments, and monoclonal antibodies.
-
Canopus provides network and security teams with real-time, high-fidelity intelligence to inform faster decision-making. Their SEER (Sense, Examine, Evaluate & Respond) platform uses agentic AI workflows to translate data collected from lightweight sensors into contextualised information.
-
CNLABS is a globally accredited lab that offers product certification and testing for network equipment. It specialises in emerging technologies like software defined networking, network visualisation, the cloud, internet-of-things (IoT) and IPv6. ÌýTheir services include third-party testing, regulatory compliance, interoperability testing and security testing.
-
Diraq is a world leader in silicon quantum dot computing. Their hardware can be manufactured at scale using existing silicon chip manufacturing plants, paving the way for the billions of qubits that will be needed for the quantum future.
-
Dovetail converts existing airframes into zero emissions commercial aircraft for short flights using electric motors, batteries and hydrogen. Their Dovepack product is a high-voltage, lightweight aerospace battery made from lithium-ion cells. They are also developing a battery-powered version of the Cessna Caravan and a hydrogen fuel cell version of the Beechcraft King Air.
-
Drop Bio improves the accuracy of pathology tests on samples collected at home. Their Remote Control API uses environmental sensor data to adjust test results and compensate for degradation of the sample that occurs during transit. Better at-home testing opens up new opportunities for decentralised clinical trials, population health screening, chronic condition management and remote access to pathology services.
-
FSI develop products for three markets: fire protection, solar energy and defence. Their FIRECOAT Exterior paint, made in collaboration with ÑÇÃÀÆåÅÆ, contains new polymer technology that enables buildings to withstand very high-risk fire conditions.Ìý
-
Luminesce Alliance supports precision medicine research for children with cancer, rare diseases and neurodevelopmental disorders. Precision medicine targets treatments to an individual based on their genomic, biological and clinical data. It’s particularly important for children because 80% of rare diseases have a neurological component and 15-20% of childhood cancers appear to be associated with an underlying genetic predisposition.
-
Minimum Bio conducts fast and agnostic drug target identification for the pharmaceutical industry. Their Mercuriousâ„¢ technology allows for a parallel approach to finding potential targets of drug candidates and enables fail-fast and fail-cheap decisions in drug discovery.Ìý
-
Ocius develops uncrewed autonomous vessels (UAVs) that are fully powered by renewable energy. The UAVs are used for maritime surveillance, scientific exploration and the prevention of illegal fishing activities.
-
Omico is changing the way we fight cancer by accelerating access to precision oncology. They use genomic profiling to detect unique genetic variations in cancer tumours and identify potential matches to targeted treatment options.
-
RNA Fold develop AI algorithms for better RNA therapeutics. By training the algorithms on unique datasets based on the structure of target RNAs and potential drug compounds, including binding experiments and toxicity profiles, their model predicts successful drugs faster and with 100x better accuracy.
-
SQC’s goal is to deliver a programmable device based on a one hundred qubit processor embodying error correction by 2028. A spinout from ÑÇÃÀÆåÅÆ technology, SQC has invested over A$15M into specialist equipment and outputs, including scanning tunnelling microscopes (STMs), dilution fridges that operate at a cool 0.003K and electron beam lithography devices.
-
Swan Genomics have created a new approach to DNA sequencing to deliver more accessible genomics data to existing and new markets.
-
Vecor provides novel solutions in ceramics and renewable energy storage. Their products improve the performance of coatings, ceramics, plastics, PVC and other polymers while reducing manufacturer costs and supply chain risks.
-
Xylo pioneers next-generation therapeutics designed to rewire neural circuits and restore brain function in patients who experience psychiatric and neurological disorders. They combine expertise in medicinal chemistry with computational drug discovery to develop small molecules that promote neuroplasticity while avoiding undesirable side effects.
-